SERUM LEVELS OF INTERLEUKIN-1β ALONG WITH ITS GENETIC POLYMORPHISM IN PATIENTS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Read full text Summarise with VIRAT
Authors: AMBER, DEVENDRA KUMAR SINGH, S.B. SHARMA, THURAYA ABDULSALAM A.A. ALAZAZI, MOHIT KUMAR, NIRUPMA GUPTA, Manoj Kumar Nandkeoliar
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Background: Chronic Obstructive Pulmonary Disease (COPD) is a progressive inflammatory lung disorder characterized by persistent airflow limitation and systemic inflammation. Interleukin-1β (IL-1β), a key pro-inflammatory cytokine, has been implicated in COPD pathogenesis; however, data on its serum levels and genetic polymorphisms in the Indian population remain limited. Material & Methods: A case–control study was conducted involving 160 participants, comprising 80 COPD patients and 80 healthy controls aged ≥40 years. Serum IL-1β levels were measured using sandwich ELISA. Genotyping of IL-1β polymorphism was performed using ARMS-PCR following DNA extraction. Results: Levels of serum IL-1β were significantly higher in the COPD group at 2.28 (1.7–2.685) pg/dl compared to 1.52 (1.05–2.17) pg/dl in controls (p < 0.0001). The CC genotype was significantly more frequent among COPD patients (32.5%) than controls (15%), whereas the TT genotype was more prevalent in controls (43.75% vs 17.5%; p=0.0006). The C allele was significantly associated with increased COPD risk (57.5% vs 35.63%; p

Fields of Study & Subjects

Chronic Obstructive Pulmonary Disease (COPD) Research Asthma and respiratory diseases Genetic Associations and Epidemiology

Publication details

Journal / source
Journal of Tianjin University Science and Technology
Publication date
23 February 2026
Language
EN